We first investigated HUGL-1, YAP, c-MYC and activated Caspase 3 (hereafter referred to as Cas3) distribution in colon cancers, where HUGL-1 alterations have been associated with malignant progression37. This evidence concerns the gene EFS and colonic neoplasm.